Terms: = Melanoma AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
47 results:
1. Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT).
Fantoni A; Warburton L; Solomon B; Alexander M; Maddula M; Brown LJ; da Silva IP; Nagrial A; Abu Al-Hial F; Itchins M; Pavlakis N; Bowyer S
Clin Lung Cancer; 2024 Jul; 25(5):449-459. PubMed ID: 38705835
[TBL] [Abstract] [Full Text] [Related]
2. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Expression Profiling Reveals Molecular Markers Involved in the Progression of Cutaneous melanoma towards Metastasis.
Lazăr AD; Dinescu S; Sleiman L; Dumitru AV; Costache M; Costache M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047539
[TBL] [Abstract] [Full Text] [Related]
4. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract] [Full Text] [Related]
5. Theranostic Activity of Ceria-Based Nanoparticles toward Parental and Metastatic melanoma: 2D
K Johnson K; Kopecky C; Koshy P; Liu Y; Devadason M; Holst J; A Kilian K; C Sorrell C
ACS Biomater Sci Eng; 2023 Feb; 9(2):1053-1065. PubMed ID: 36726306
[TBL] [Abstract] [Full Text] [Related]
6. Utility of Single-Gene Testing in Cancer Specimens.
Hanbazazh M; Morlote D; Mackinnon AC; Harada S
Clin Lab Med; 2022 Sep; 42(3):385-394. PubMed ID: 36150818
[TBL] [Abstract] [Full Text] [Related]
7. Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
Sheffield BS; Beharry A; Diep J; Perdrizet K; Iafolla MAJ; Raskin W; Dudani S; Brett MA; Starova B; Olsen B; Cheema PK
Curr Oncol; 2022 Feb; 29(3):1326-1334. PubMed ID: 35323313
[No Abstract] [Full Text] [Related]
8. Assessing the Association of Targeted Therapy and Intracranial Metastatic Disease.
Erickson AW; Habbous S; Wright F; Lofters AK; Jerzak KJ; Das S
JAMA Oncol; 2021 Aug; 7(8):1220-1224. PubMed ID: 34081080
[TBL] [Abstract] [Full Text] [Related]
9. Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.
Marini A; Bernardini A; Gigli GL; Valente M; Muñiz-Castrillo S; Honnorat J; Vogrig A
Neurology; 2021 Apr; 96(16):754-766. PubMed ID: 33653902
[TBL] [Abstract] [Full Text] [Related]
10. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract] [Full Text] [Related]
11. Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
Guerreiro EM; Øvstebø R; Thiede B; Costea DE; Søland TM; Kanli Galtung H
PLoS One; 2020; 15(9):e0238591. PubMed ID: 32886718
[TBL] [Abstract] [Full Text] [Related]
12. Management of brain metastases according to molecular subtypes.
Soffietti R; Ahluwalia M; Lin N; Rudà R
Nat Rev Neurol; 2020 Oct; 16(10):557-574. PubMed ID: 32873927
[TBL] [Abstract] [Full Text] [Related]
13. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
[TBL] [Abstract] [Full Text] [Related]
14. Skin Architecture, Kidney Transplantation, and Their Relationship to Basal and Squamous Cell Carcinomas.
Capasso A; Bilancio G; Lee MW; Palladino G; Pollastro RM; Simeoni M; Secondulfo C; Ronchi A; Caputo A; Franco R; Zeppa P; Capasso G; Viggiano D
Anticancer Res; 2020 Jul; 40(7):4017-4022. PubMed ID: 32620646
[TBL] [Abstract] [Full Text] [Related]
15. [Cutaneous squamous cell carcinoma].
Leiter U; Gutzmer R; Alter M; Ulrich C; Meiwes A; Heppt MV; Steeb T; Berking C; Lonsdorf AS; Sachse MM; Garbe C; Hillen U
Hautarzt; 2020 Aug; 71(8):597-606. PubMed ID: 32583034
[TBL] [Abstract] [Full Text] [Related]
16. Rapid clinical mutational testing of
Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B
J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605
[TBL] [Abstract] [Full Text] [Related]
17. Multidisciplinary expert opinion on the treatment consensus for patients with egfr mutated NSCLC with brain metastases.
Ponce S; Bruna J; Juan O; López R; Navarro A; Ortega AL; Puente J; Verger E; Bartolomé A; Nadal E
Crit Rev Oncol Hematol; 2019 Jun; 138():190-206. PubMed ID: 31092376
[TBL] [Abstract] [Full Text] [Related]
18. Survival and prognostic factors in surgically treated brain metastases.
Kavouridis VK; Harary M; Hulsbergen AFC; Lo YT; Reardon DA; Aizer AA; Iorgulescu JB; Smith TR
J Neurooncol; 2019 Jun; 143(2):359-367. PubMed ID: 30989623
[TBL] [Abstract] [Full Text] [Related]
19. Uncommon Presentation of Metastatic Squamous Cell Carcinoma of the Skin and Treatment Challenges.
Pandey A; Liaukovich M; Joshi K; Avezbakiyev BI; O'Donnell JE
Am J Case Rep; 2019 Mar; 20():294-299. PubMed ID: 30837448
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma.
Harbhajanka A; Chahar S; Miskimen K; Silverman P; Harris L; Williams N; Varadan V; Gilmore H
Hum Pathol; 2018 Oct; 80():163-169. PubMed ID: 29894722
[TBL] [Abstract] [Full Text] [Related]
[Next]
